The PanOptix intraocular lens implant (IOL) for cataract patients is now available at Valley Eye Associates. It is the first and only FDA-approved trifocal lens to replace the eye’s natural lens after cataract surgery!
If you’re over the age of 45, you may be noticing changes in your vision. Colors may be less vivid, reading without glasses may be difficult, you may require more light to read, and your vision may be blurry or hazy. These are all common symptoms of cataracts and presbyopia—vision conditions that affect the majority of people as they age.
Vision following cataract surgery with the PanOptix lens exceeds previously unattainable levels with older technology. The PanOptix lens provides patients with:
- Outstanding range of vision—near, far, and in-between
- Brighter, more vivid colors
- Less dependence on glasses or contacts
“I have been very impressed with the latest generation of multifocal intraocular lens implants,” says Dr. Michael Vrabec. “The trifocal multifocal IOL, called the Alcon PanOptix lens, has been used overseas for many years with excellent results. It was approved by the FDA for use in the United States in the last half of 2019 and I began offering it to patients shortly after its approval. With over 50 patients having had this IOL implanted in their eyes, I have found the lens to have even better distance, intermediate, and near vision without glasses when compared to older generation of bifocal multifocal IOLs, better vision in low light, and less glare and halos at night.”
To schedule your cataract examination and learn more about the PanOptix lOL, please call Valley Eye Associates at (800) 344-4443.